Results 111 to 120 of about 5,445 (182)

SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Tantush A, Ben Hamida B, Sagher M, Afsheen N, Sager M, Abusbaeh A, Tantoush M, Abusbaeh A, Najaim A, Alhamadi M, Hesham Gamal M, Alemam MM, Elhady MM.   +12 more
europepmc   +1 more source

The PKD Daily: Development and Content Validation of a Hybrid Diary for Tracking Urinary Events in Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD). [PDF]

Adv Ther
O'Connor M, Broderick L, Waldman LT, Costa E, Carty M, Nunna S, Oberdhan D.   +6 more
europepmc   +1 more source

Refractory hyponatremia in small cell lung cancer: a case report and literature review. [PDF]

Front Endocrinol (Lausanne)
Bao S, Qin L, Zhang Y, Jiang X, Duan L.
europepmc   +1 more source

Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Chang CH, Kuo YC, Kuan YH, Lim PS, Chung MC, Pan YR, Luo CW, Wu TK.   +7 more
europepmc   +1 more source

Advances in the Treatment of Autosomal Dominant Polycystic Kidney Disease and Novel Therapeutic Targets. [PDF]

Curr Issues Mol Biol
Zhang W, Sun T, Wang X, Jiang T.
europepmc   +1 more source

Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry. [PDF]

Can J Kidney Health Dis
McFarlane P, Bichet DG, Alam A, Bubolic S, Laplante A.   +4 more
europepmc   +1 more source

Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial. [PDF]

J Clin Endocrinol Metab
Warren AM, Grossmann M, Hoermann R, Lin R, Zajac JD, Russell N.   +5 more
europepmc   +1 more source

Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL. [PDF]

Kidney Med
Jaiyen N, Chinpraditsuk S, Pattharanitima P, Tantiyavarong P, Krisanapan P.   +4 more
europepmc   +1 more source

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis. [PDF]

JACC Adv
Lima IG, Nunes JT, Luk AC, Brahmbhatt DH, Godoy LC, McDonald M, Billia F, Bocchi EA.   +7 more
europepmc   +1 more source